anand-1
JOHAN_R / SHUTTERSTOCK.COM
16 June 2015AsiaPravin Anand

Tackling India's patent delays

While patent office delays and the excessive backlog of pending patent applications at the Indian Patent Office (IPO) have been an issue of serious concern for a while, it is only recently that the problem has been seriously dealt with and exposed via two writ petitions before the Delhi High Court filed by Nitto Denko Corporation, a company based in Japan.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Asia
31 March 2026   The clash between one of India’s largest B2B marketplaces and the country’s drugs regulator challenges the “passive” position of such platforms with regards to allegedly unlawful pharmaceutical listings, says Aarti Aggarwal of Remfry & Sagar.
Asia
20 March 2026   As the patent protecting semaglutide—the drug that made Novo Nordisk one of Europe's most valuable companies—expires in ten countries, the pressure mounts for prices and market leaders alike.
Asia
5 February 2026   The British-Swedish pharma giant pays $1.2 billion upfront for access to next-generation weight-loss treatment as China patent cliff changes the market.